12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
ContraFect (NASDAQ:CFRX) stock increased by 4.9% to $2.76 during Thursday's after-market session. The company's market cap stands at $108.5 million.
Plus Therapeutics Expands Investigational Oncology Drug Pipeline
Plus Therapeutics, Inc (NASDAQ:PSTV) has entered into an agreement with The University of Texas Health Science Center at San Antonio for…
34 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 49.7% to $15.45 after the company announced it acquired exclusive rights to novel mRNA biomarkers.
45 Biggest Movers From Yesterday
Gainers
ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55.
The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives
Here's a roundup of top developments in the biotech space over the last 24 hours:
Plus Therapeutics Shares Shine After Two Milestones To Manufacture Its Lead Radiotherapeutic
Plus Therapeutics Inc (NASDAQ: PSTV) has
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
Plus Therapeutics Receives FDA Fast Track Designation For 186RNL Targeted Radiotherapeutic For Leptomeningeal Metastases
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced